Home›Stock Screener›Hester Biosciences›Intrinsic Value

Hester Biosciences Intrinsic Value

Hester Biosciences intrinsic value. Hester Biosciences (HESTERBIO) median intrinsic value is ₹965.93 from 10 valuation models (range ₹706–₹2107), vs current price ₹2352.10 — -58.9% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse Hester Biosciences ownership pattern to track promoter, FII and institutional holdings.

Market Price (CMP)
₹2352.10
Primary Intrinsic Value
₹2106.72
Market Cap
₹2117 Cr
-58.9% Downside
Median Value
₹965.93
Value Range
₹706 - ₹2107
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

HESTERBIO Valuation Methods Summary — DCF, Graham Number & P/E

Hester Biosciences intrinsic value across 10 models vs current price ₹2352.10 — upside/downside and value range per method. For current market price and key ratios, visit HESTERBIO screener.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹2106.72 ₹1685.38 - ₹2528.06 -10.4% EPS: ₹95.76, Sector P/E: 22x
Book Value Method asset ₹817.78 ₹736.00 - ₹899.56 -65.2% Book Value/Share: ₹408.89, P/B: 2.0x
Revenue Multiple Method revenue ₹906.67 ₹816.00 - ₹997.34 -61.5% Revenue/Share: ₹453.33, P/S: 2.0x
EBITDA Multiple Method earnings ₹1644.44 ₹1480.00 - ₹1808.88 -30.1% EBITDA: ₹148.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹965.93 ₹772.74 - ₹1159.12 -58.9% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹705.63 ₹635.07 - ₹776.19 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹1479.49 ₹1331.54 - ₹1627.44 -37.1% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹1493.33 ₹1344.00 - ₹1642.66 -36.5% ROE: 22.8%, P/E Multiple: 16x
Graham Defensive Method conservative ₹817.78 ₹736.00 - ₹899.56 -65.2% EPS: ₹95.76, BVPS: ₹408.89
Dividend Yield Method dividend ₹705.63 ₹635.07 - ₹776.19 -70.0% DPS: ₹11.00, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

HESTERBIO Intrinsic Value vs Market Price — All Valuation Models

Hester Biosciences fair value range ₹706–₹2107 vs current market price ₹2352.10 across 10 valuation models. Browse HESTERBIO financial statements for revenue, profit, balance sheet and cash flow data.

HESTERBIO Intrinsic Value Analysis — Undervalued or Overvalued?

Hester Biosciences median intrinsic value ₹965.93, current price ₹2352.10 — Trading Above Calculated Value by 58.9%, margin of safety -100.0%.

What is the intrinsic value of HESTERBIO?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Hester Biosciences (HESTERBIO) is ₹965.93 (median value). With the current market price of ₹2352.10, this represents a -58.9% variance from our estimated fair value.

The valuation range spans from ₹705.63 to ₹2106.72, indicating ₹705.63 - ₹2106.72.

Is HESTERBIO undervalued or overvalued?

Based on our multi-method analysis, Hester Biosciences (HESTERBIO) appears to be trading above calculated value by approximately 58.9%.

HESTERBIO Financial Health — Key Ratios vs Industry Benchmarks

Hester Biosciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 22.8% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 33.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.60x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

HESTERBIO Cash Flow Quality — Operating & Free Cash Flow

Hester Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹64 Cr ₹55 Cr Positive Free Cash Flow 8/10
March 2025 ₹65 Cr ₹55 Cr Positive Free Cash Flow 8/10
March 2024 ₹48 Cr ₹37 Cr Positive Free Cash Flow 8/10
March 2023 ₹24 Cr ₹-15 Cr Positive Operating Cash Flow 6/10
March 2022 ₹9 Cr ₹-50 Cr Positive Operating Cash Flow 6/10